ArticleScientific reports2025
Functional characterization of grammicin biosynthesis genes in Xylaria grammica and strategies for enhanced metabolite production.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comparative Transcriptome Analysis ofMycobiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Fungi produce diverse secondary metabolites with agricultural and medical potential. Xylaria grammica EL000614 synthesizes grammicin, an isomer of patulin, which shows nematicidal activity against root-knot nematodes with low cytotoxicity. However, the genetic basis of grammicin biosynthesis remains unclear. Here, we characterized two genes, xgpatK and xgpatL, encoding a 6-methylsalicylic acid synthase XgPatK and a Zn(II)2Cys6 transcription factor XgPatL, respectively, within a putative grammicin biosynthetic cluster. Comparative genomic analysis identified 11 cluster genes in X. grammica that are also conserved in patulin-producing fungi, including Aspergillus clavatus and Penicillium expansum. Deletion of xgpatK or xgpatL abolished grammicin production, while complementation restored it, confirming their essential roles. Furthermore, constitutive overexpression of xgpatL increased grammicin production three-fold compared with the wild-type. These findings provide the first genetic and functional evidence of grammicin biosynthesis in X. grammica and demonstrate the regulatory role of XgPatL. Our study advances the understanding of fungal secondary metabolism and highlights grammicin as a potential agent for sustainable biological control of plant-parasitic nematodes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.